Tag : HbA1c

Type 2 diabetes mellitus (T2DM) has long been associated with an increased risk of liver-related complications, including hepatic decompensation, hepatocellular carcinoma, and liver-related mortality. While elevated glycated hemoglobin A1c (HbA1c) levels are a known risk factor, the influence of HbA1c trajectories over time on liver outcomes remains poorly understood. To address this, a territory-wide cohort study was conducted in Hong Kong to evaluate the impact of HbA1c trajectories on the development of liver-related complications in patients with T2DM.1 During the AASLD Annual Meeting 2024, Dr. Yip, Cheuk-Fung Terry from The Chinese University of Hong Kong, presented the study findings.